Kidney Clinic

  • Meet the Team

    The Kidney Clinic, part of the Division of Nephrology and Hypertension, is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty and staff.

  • Show All

    Faculty

    A photo of Prasad Devarajan.

    Prasad Devarajan, MD
    Director, Division of Nephrology and Hypertension

    513-636-4531

    prasad.devarajan@cchmc.org

    Prasad Devarajan, MD

    Director, Division of Nephrology and Hypertension

    Medical Director, Stone Center

    Director, Nephrology and Hypertension Clinical Laboratory

    Louise M. Williams Endowed Chair

    Professor, UC Department of Pediatrics

    Phone: 513-636-4531

    Fax: 513-636-7407

    Email: prasad.devarajan@cchmc.org

    Show All

    Specialties

    Clinical specialties: Acute kidney injury, nephrotic syndrome, kidney stones

    Visit the Devarajan Lab.

    Education and Training

    Premedical Studies: Bombay University, India, 1979. 

    MD: Bombay University, India, 1985.

    Publications

    View PubMed Publications
    A photo of Jens W. Goebel.

    Jens W. Goebel, MD
    Clinical Director, Nephrology and Hypertension

    513-636-4531

    jens.goebel@cchmc.org

    Jens W. Goebel, MD

    Clinical Director, Nephrology and Hypertension

    Medical Director, Kidney Transplantation

    Clinical Director, Kidney Transplantation

    Professor, UC Department of Pediatrics

    Phone: 513-636-4531

    Fax: 513-636-7407

    Email: jens.goebel@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Organ transplantation in children

    Research Interests

    Transplant-relevant immunology 

    Biography

    Dr. Goebel was recruited by Cincinnati Children's Hospital Medical Center in 2002 from the University of Kentucky to enhance the institution's Kidney Transplant Program. His efforts along these lines focus both on further improving the clinical care of pediatric kidney transplant recipients and their families, as well as advancing basic and translational investigations into immunological aspects especially relevant to the field of transplantation.

    Education and Training

    MD: University of Heidelberg (Germany), 1991.

    Residency and Chief Residency: Department of Pediatrics, University of South Alabama, Mobile, AL, 1991 to 1995.

    Fellowship: Section of Pediatric Nephrology, Tulane University Medical Center, New Orleans, LA, 1995 to 1998.

    Certifications: General Pediatrics, 1994, 2002; Pediatric Nephrology, 1999.

    Publications

    View PubMed Publications

    Grants

    Center-PI / Co-Investigator / Collaborator:

    NIH UO1 grant: Noninvasive Monitoring to Predict Outcome in de novo Kidney Transplant Recipients (CTOT-01, Protocol Chair: P. Heeger, MD, City), commenced in late 2005 and ongoing

    NIH UO1 grant: Health and Literacy in Child and Adult Assessment: Expanded Testing of the Pediatric PROMIS (Patient Reported Outcomes Measurement Information System) Tool (Sponsor: D. DeWalt, MD, MPH, ), ongoing.

    NIH UO1 grant: Chronic Kidney Disease in Children (CKID, PI: B. Warady, MD, Children’s Mercy Hospital, Kansas City, MO), ongoing.

    NIH RO1 grant: Calcineurin Inhibitor Minimization And Foxp3+ Tregs Post-Transplant (PIs: Wayne Hancock, MD, Children’s , and John Bucuvalas, MD, Cincinnati Children’s Hospital), ongoing.

    Midwest Pediatric Nephrology Consortium: Assessing and Implementing Transition to Adult Care in Children with CKD (PI: M. Ferris, MD, MPH, PhD, ), ongoing

    Amgen Pharmaceuticals: Pediatric Anemia Correction Study (Protocol 20050256), ongoing.

    Roche Pharmaceuticals: Development of Population Pharmacokinetic models of Mycophenolic Acid for use in Bayesian Dose Individualization in Pediatric Kidney Transplant Patients (PI: A. Vinks, Cincinnati Children’s Hospital), ongoing.

    Cincinnati Children’s Hospital Medical Center Outcomes Research Award: Validation of a Real-Time Adherence Assessment System (PI: A. Pai, PhD, Cincinnati Children’s Hospital), ongoing.

    Cincinnati Children’s Hospital Medical Center Translational Research Initiative grant: Pharmacogenetics of Mycophenolic Acid in Kidney Transplant Patients (PI: A. Vinks, Cincinnati Children’s Hospital), ongoing.

    Cincinnati Children’s Hospital Medical Center Translational Research Initiative grant: Biomarkers for Patient-tailored Therapies in Pediatric Lupus Nephritis using Mycophenolic Acid (PI: H. Brunner, Cincinnati Children’s Hospital), ongoing.

    Cincinnati Children’s Hospital Medical Center Translational Research Initiative grant: Pharmacogenetics of IMPDH in Kidney Transplant Patients (PI: A. Vinks, Cincinnati Children’s Hospital), ongoing.


    A photo of Mark Mitsnefes.

    Mark M. Mitsnefes, MD, MS
    Director, Clinical and Translational Research Center

    513-636-0125

    mark.mitsnefes@cchmc.org

    Mark M. Mitsnefes, MD, MS

    Director, Clinical and Translational Research Center

    Pediatric Nephrologist

    Professor, UC Department of Pediatrics

    Phone: 513-636-0125

    Fax: 513-636-7407

    Email: mark.mitsnefes@cchmc.org

    Show All

    Specialties

    Nephrology with focus on chronic kidney disease and hypertension

    Biography

    Mark Mitsnefes, MD, MS, is an established clinical investigator with expertise in the area of understanding the development of risk factors for cardiovascular disease in children with chronic kidney disease. The long-term goal of his research is to define biologic targets for interventions to prevent and slow progression of cardiovascular disease in children with chronic kidney disease.

    Dr. Misnefes has received numerous awards, including the Proctor Scolar Award (Cincinnati Children's Research Foundation), the Pediatrician Scientist Award (Children's Health Research Center, NIH), the Clinical Scientist Award (National Kidney Foundation), and has been ranked as one of the Best Doctors in America, 2007-2011.

    Education and Training

    MD: Gorky Medical Institute, Gorky, Russia, 1985.

    Residency: Miami Children's Hospital, Miami, Florida, 1997.

    Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2000.

    MS: Epidemiology and Biostatistics, University of Cincinnati, Cincinnati, Ohio, 2001.

    Certifications: Educational Commission for Foreign Medical Graduates (ECFMG), 1995; Pediatrics, 1996; Pediatric Nephrology, 2001, 2008.

    Publications

    View PubMed Publications

    Grants

    Adiponectin and Cardiovascular Disease in the CKiD Children. Principal Investigator. National Institutes of Health. 2007 - 2011. #R01 DK076957.

    Modify Dietary Behavior in Adolescents with Elevated Blood Pressure. Co-investigator. National Institutes of Health. 2007 - 2012.

    Prospective study of chronic kidney disease in children. Co-investigator, Co-chair of the Cardiovascular Committee. National Institutes of Health. 2003 - 2013. #U01 DK-03-012.

    Cardiovascular disease in children with CKD. Principal Investigator. National Institutes of Health. 2011 - 2016. #K24 DK090070-01.

    A photo of Edward Nehus.

    Edward J. Nehus, MD, MS
    Pediatric Nephrologist

    513-636-4531

    edward.nehus@cchmc.org

    Edward J. Nehus, MD, MS

    Pediatric Nephrologist

    Instructor, UC Department of Pediatrics

    Phone: 513-636-4531

    Email: edward.nehus@cchmc.org

    Show All

    Specialties

    Critical care nephrology; chronic kidney disease

    Biography

    Edward conducted and published a cross-sectional study which investigated the association of serum resistin with cardiovascular risk factors in children with chronic kidney disease.  In addition, he recently published a study evaluating the outcomes steroid-avoidance protocols in pediatric kidney transplant recipients.  He continues to be the primary investigator for ongoing studies that explore pharmacokinetic alterations in critically ill children receiving continuous renal replacement therapy.

    Education and Training

    MD: University of Toledo, Toledo, OH, 2002.

    MS: University of Cincinnati, Cincinnati, OH, 2011.

    Residency: Pediatrics, Nationwide Children’s Hospital, Columbus, OH.

    Certification: Pediatrics, 2009.

    Fellowship: Pediatric Nephrology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

    Publications

    View PubMed Publications

    A photo of Frederic Strife.

    C. Frederic Strife, MD
    Emeritus Professor

    513-636-4531

    fred.strife@cchmc.org

    C. Frederic Strife, MD

    Emeritus Professor

    Director of the Dialysis Unit

    Professor, UC Department of Pediatrics

    Phone: 513-636-4531

    Fax: 513-636-7407

    Email: fred.strife@cchmc.org

    Show All

    Specialties

    Glomerulonephritis; renal tubular disorders; growth failure in chronic renal disease; dialysis

    Education and Training

    MD: College of Medicine and Dentistry of New Jersey, 1968.

    Residency: Pediatrics, Children's Hospital Medical Center, Cincinnati, OH.

    Fellowship: Nephrology, Children's Hospital Medical Center, Cincinnati, OH.

    Certification: Pediatrics, 1973; Pediatric Nephrology, 1976.

    Publications

    View PubMed Publications
    A photo of Rene Van de Voorde.

    Rene G. Van De Voorde III, MD
    Medical Director, Dialysis Unit

    513-636-4531

    rene.vandevoorde@cchmc.org

    Rene G. Van De Voorde, MD

    Medical Director, Dialysis Unit

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4531

    Fax: 513-636-7407

    Email: rene.vandevoorde@cchmc.org

    Show All

    Specialties

    Dialysis; primarily infant dialysis; chronic kidney disease; acute kidney injury; hypertension

    Education and Training

    MD: Vanderbilt University.

    Residency: Pediatrics, Cincinnati Children's Hospital.

    Chief Resident: Pediatrics, Cincinnati Children's Hospital.

    Fellowship: Pediatric Nephrology, Cincinnati Children's Hospital.

    Certification: Pediatrics, 2003; Pediatric Nephrology, 2008.

    Publications

    View PubMed Publications

    Grants

    Prospective, Multicenter Study to Evaluate the Safety of Vitamin D Receptor Activators as Determined by Hypercalcemia in Pediatric Patients ages 0 to 16 with Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis within Current Clinical Practice. Site- Principal Investigator. Jun 2010 - present.

    Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared with Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects with Dialysis dependent Chronic Kidney Disease. Site Co-investigator. AMAG Pharmaceutical. Apr 2011 - present.

    Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared with Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects with Non-dialysis dependent Chronic Kidney Disease. Site-Principal Investigator. AMAG Pharmaceuticals. Apr 2011 - present.